Universal Beteiligungs Und Servicegesellschaft Mb H Cytom X Therapeutics, Inc. Transaction History
Universal Beteiligungs Und Servicegesellschaft Mb H
- $47.1 Billion
- Q1 2025
A detailed history of Universal Beteiligungs Und Servicegesellschaft Mb H transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Universal Beteiligungs Und Servicegesellschaft Mb H holds 97,123 shares of CTMX stock, worth $91,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,123Holding current value
$91,295% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
70Shares Held
46.2MCall Options Held
3.7KPut Options Held
4.7K-
Tang Capital Management LLC San Diego, CA7.31MShares$6.87 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.91 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.12MShares$4.81 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$3.67 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$3.03 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $62M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...